These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2049046)

  • 1. Cellular immune response to Borrelia burgdorferi in patients with Lyme borreliosis.
    Krause A; Rensing A; Kalden JR; Burmester GR
    Behring Inst Mitt; 1991 Feb; (88):52-8. PubMed ID: 2049046
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunology of Lyme disease.
    Sigal LH
    N J Med; 1990 Jul; 87(7):567-71. PubMed ID: 2200983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the pathogenesis and treatment of Lyme arthritis.
    Franz JK; Priem S; Rittig MG; Burmester GR; Krause A
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):981-4. PubMed ID: 10666814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial measurement of soluble interleukin 2 receptor levels: an early indicator of treatment response for Lyme disease.
    Fawcett PT; Rose CD; Proujansky R; Gibney KM; Molloy DM; Doughty RA
    J Rheumatol; 1993 Jun; 20(6):996-8. PubMed ID: 8350338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it thee or me?--autoimmunity in Lyme disease.
    Klempner MS; Huber BT
    Nat Med; 1999 Dec; 5(12):1346-7. PubMed ID: 10581067
    [No Abstract]   [Full Text] [Related]  

  • 7. T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation.
    Krause A; Brade V; Schoerner C; Solbach W; Kalden JR; Burmester GR
    Arthritis Rheum; 1991 Apr; 34(4):393-402. PubMed ID: 2012626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocyte proliferation test in cutaneous manifestations of Lyme borreliosis].
    Breier F; Klade H; Stanek G
    Wien Med Wochenschr; 1995; 145(7-8):170-3. PubMed ID: 7610666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma.
    Breier P; Klade H; Stanek G; Poitschek C; Kirnbauer R; Dorda W; Aberer E
    Br J Dermatol; 1996 Feb; 134(2):285-91. PubMed ID: 8746343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection.
    Pohl-Koppe A; Balashov KE; Steere AC; Logigian EL; Hafler DA
    J Immunol; 1998 Feb; 160(4):1804-10. PubMed ID: 9469440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suspected Lyme borreliosis: how to diagnose, whom to treat?].
    Bernasconi E; Nadal D; Vogt M
    Ther Umsch; 1992 Apr; 49(4):257-62. PubMed ID: 1615461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lyme arthritis].
    Barskova VG; Anan'eva LP; Skripnikova IA; Nasonova VA
    Ter Arkh; 1993; 65(12):82-7. PubMed ID: 8146783
    [No Abstract]   [Full Text] [Related]  

  • 13. Preferential usage of T cell antigen receptor V region gene segment V beta 5.1 by Borrelia burgdorferi antigen-reactive T cell clones isolated from a patient with Lyme disease.
    Lahesmaa R; Shanafelt MC; Allsup A; Soderberg C; Anzola J; Freitas V; Turck C; Steinman L; Peltz G
    J Immunol; 1993 May; 150(9):4125-35. PubMed ID: 7682589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease.
    Hemmer B; Gran B; Zhao Y; Marques A; Pascal J; Tzou A; Kondo T; Cortese I; Bielekova B; Straus SE; McFarland HF; Houghten R; Simon R; Pinilla C; Martin R
    Nat Med; 1999 Dec; 5(12):1375-82. PubMed ID: 10581079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity of Borrelia burgdorferi and myelin basic protein-specific T cells is not observed in borrelial encephalomyelitis.
    Pohl-Koppe A; Logigian EL; Steere AC; Hafler DA
    Cell Immunol; 1999 May; 194(1):118-23. PubMed ID: 10357888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunodiagnosis of Lyme borreliosis.
    Dattwyler RJ; Luft BJ
    Rheum Dis Clin North Am; 1989 Nov; 15(4):727-34. PubMed ID: 2685927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi.
    Chen J; Field JA; Glickstein L; Molloy PJ; Huber BT; Steere AC
    Arthritis Rheum; 1999 Sep; 42(9):1813-22. PubMed ID: 10513794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis.
    Steere AC; Gross D; Meyer AL; Huber BT
    J Autoimmun; 2001 May; 16(3):263-8. PubMed ID: 11334491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model for Borrelia burgdorferi infection: pathogenesis, immune response and protection.
    Schaible UE; Wallich R; Kramer MD; Museteanu C; Simon MM
    Behring Inst Mitt; 1991 Feb; (88):59-67. PubMed ID: 2049047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.